Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 2
2012 5
2013 5
2014 7
2015 10
2016 7
2017 8
2018 8
2019 11
2020 12
2021 21
2022 25
2023 34
2024 29
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D. Devinsky O, et al. Among authors: jutras aswad d. Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. Epilepsia. 2014. PMID: 24854329 Free PMC article. Review.
Letter in Reply.
Hassan AN, Wild C, Jutras-Aswad D. Hassan AN, et al. Among authors: jutras aswad d. J Addict Med. 2023 Nov-Dec 01;17(6):746. doi: 10.1097/ADM.0000000000001203. Epub 2023 Jul 27. J Addict Med. 2023. PMID: 37934553 No abstract available.
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
Tourjman SV, Buck G, Jutras-Aswad D, Khullar A, McInerney S, Saraf G, Pinto JV, Potvin S, Poulin MJ, Frey BN, Kennedy SH, Lam RW, MacQueen G, Milev R, Parikh SV, Ravindran A, McIntyre RS, Schaffer A, Taylor VH, van Ameringen M, Yatham LN, Beaulieu S. Tourjman SV, et al. Among authors: jutras aswad d. Can J Psychiatry. 2023 May;68(5):299-311. doi: 10.1177/07067437221099769. Epub 2022 Jun 16. Can J Psychiatry. 2023. PMID: 35711159 Free PMC article. Review.
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sharafi H, Bakouni H, McAnulty C, Drouin S, Coronado-Montoya S, Bahremand A, Bach P, Ezard N, Le Foll B, Schütz CG, Siefried KJ, Tardelli VS, Ziegler D, Jutras-Aswad D. Sharafi H, et al. Among authors: jutras aswad d. Addiction. 2024 Feb;119(2):211-224. doi: 10.1111/add.16347. Epub 2023 Oct 25. Addiction. 2024. PMID: 37880829 Review.
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Bakouni H, Sharafi H, Bahremand A, Drouin S, Ziegler D, Bach P, Le Foll B, Schütz CG, Tardelli V, Ezard N, Siefried K, Jutras-Aswad D. Bakouni H, et al. Among authors: jutras aswad d. Drug Alcohol Depend. 2023 Dec 1;253:111018. doi: 10.1016/j.drugalcdep.2023.111018. Epub 2023 Nov 4. Drug Alcohol Depend. 2023. PMID: 37979478 Review.
Die 'Richtlinien für die Risiko-Reduzierung beim Cannabiskonsum (RRRCK)': EMPFEHLUNGEN[The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (GERMAN)].
Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. Fischer B, et al. Among authors: jutras aswad d. Int J Drug Policy. 2023 Mar 24:103995. doi: 10.1016/j.drugpo.2023.103995. Online ahead of print. Int J Drug Policy. 2023. PMID: 36967339 No abstract available.
Les 'Lignes Directrices Pour l'Usage du Cannabis à Moindre Risque (LUCMR)': RECOMMENDATIONS [The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (FRENCH)].
Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. Fischer B, et al. Among authors: jutras aswad d. Int J Drug Policy. 2023 Apr 11:103994. doi: 10.1016/j.drugpo.2023.103994. Online ahead of print. Int J Drug Policy. 2023. PMID: 37055339 No abstract available.
Las 'Guías para el Uso de Cannabis de Menor Riesgo (GUCMR)': RECOMENDACIONES [The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (SPANISH)].
Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. Fischer B, et al. Among authors: jutras aswad d. Int J Drug Policy. 2023 Apr 11:103996. doi: 10.1016/j.drugpo.2023.103996. Online ahead of print. Int J Drug Policy. 2023. PMID: 37055340 No abstract available.
167 results